Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • trastuzumab

Tag: trastuzumab deruxtecan

You Searched For "trastuzumab deruxtecan"
AstraZeneca Enhertu shows clinically meaningful, durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial

AstraZeneca Enhertu shows clinically meaningful, durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial

Ruchika Sharma8 March 2023 7:30 AM GMT
HER2 is a tyrosine kinase receptor protein expressed on the surface of various tissue cells throughout the body and is involved in normal cell
AstraZeneca-Daiichi Sankyo Enhertu approved in China for breast cancer

AstraZeneca-Daiichi Sankyo Enhertu approved in China for breast cancer

Ruchika Sharma25 Feb 2023 8:00 AM GMT
UK: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in China as a monotherapy for the treatment of adult...
Daiichi Sankyo ENHERTU gets Japanese nod for patients with previously treated HER2 Positive Metastatic Breast Cancer

Daiichi Sankyo ENHERTU gets Japanese nod for patients with previously treated HER2 Positive Metastatic Breast Cancer

Ruchika Sharma25 Nov 2022 8:00 AM GMT
ENHERTU (trastuzumab deruxtecan, fam-trastuzumab deruxtecan-nxki in the U.S. only) is a HER2 directed ADC.
AstraZeneca- Daiichi Sankyo Enhertu recommended for nod in EU by CHMP for patients with previously treated HER2-positive advanced gastric cancer

AstraZeneca- Daiichi Sankyo Enhertu recommended for nod in EU by CHMP for patients with previously treated HER2-positive advanced gastric cancer

Ruchika Sharma15 Nov 2022 6:45 AM GMT
Enhertu is a HER2-directed ADC.
Health Bulletin 23/August/2022

Health Bulletin 23/August/2022

Roshni Dhar23 Aug 2022 11:48 AM GMT
Here are the top health news for the day:'Tomato fever' misleading colloquial name for hand, foot and mouth disease Medical professional has informed...
AstraZeneca, Daiichi Sankyo get USFDA accelerated nod for Enhertu for HER2 Mutant Non-small Cell Lung Cancer

AstraZeneca, Daiichi Sankyo get USFDA accelerated nod for Enhertu for HER2 Mutant Non-small Cell Lung Cancer

Ruchika Sharma14 Aug 2022 10:00 AM GMT
Enhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi...
AstraZeneca Enhertu secures USFDA nod for HER2-low breast cancer

AstraZeneca Enhertu secures USFDA nod for HER2-low breast cancer

Ruchika Sharma6 Aug 2022 9:00 AM GMT
Enhertu is a HER2-directed ADC.
AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use

AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use

Ruchika Sharma6 May 2022 11:38 AM GMT
The approval was granted under the FDA's Real-Time Oncology Review (RTOR) programme and converts the accelerated approval of Enhertu in later line...
Trastuzumab deruxtecan decreases risk of disease progression and death in HER2 positive breast cancer: NEJM

Trastuzumab deruxtecan decreases risk of disease progression and death in HER2 positive breast cancer: NEJM

Medical Dialogues Editorial Team30 March 2022 3:45 AM GMT
USA: A new study published in The New England Journal of Medicine shows that patients with human epidermal growth factor receptor 2 (HER2)-positive...
AstraZeneca gets CDSCO panel nod to conduct cancer drug Trastuzumab Deruxtecan study

AstraZeneca gets CDSCO panel nod to conduct cancer drug Trastuzumab Deruxtecan study

Medical Dialogues Team29 Nov 2021 12:51 PM GMT
New Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
Daiichi Sankyo Launches ENHERTU in Japan for Patients with HER2 Positive Unresectable or Metastatic Breast Cancer

Daiichi Sankyo Launches ENHERTU in Japan for Patients with HER2 Positive Unresectable or Metastatic Breast Cancer

Ruchika Sharma26 May 2020 7:23 AM GMT
Tokyo, Munich: Daiichi Sankyo Company, Limited has announced the launch of ENHERTU® (trastuzumab deruxtecan), a HER2 directed antibody drug conjugate...
AstraZeneca, Daiichi Sankyo get Orphan Drug Designation for gastric cancer drug Enhertu

AstraZeneca, Daiichi Sankyo get Orphan Drug Designation for gastric cancer drug Enhertu

Ruchika Sharma25 May 2020 6:26 AM GMT
US: Daiichi Sankyo Company Limited and AstraZeneca's Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation (ODD) in the US for the...
Next

Editorial

Journal Club Today

Health News Today

© 2022 All Rights Reserved.
Powered By: Hocalwire
X
X